Powered by
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), which develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers, reported net income of $1.7 million or 5 cents a share …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), announced that it has a new distribution agreement with Nipro Medical Corp., part of Nipro Corp. Japan. Under the terms of the agreement, Rockwell Medical …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), which manufactures and distributes hemodialysis products to dialysis providers worldwide, reported net income of $343,000 or 1 cent a share in the second quarter ended …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), the developer and manufacturer of products for dialysis providers, announced that Tim Chole was promoted to chief commercial officer, reporting to Rockwell Medical President and …
WIXOM–Rockwell Medical Inc., developers of hemodialysis products, announced that it entered into a new and expanded distribution agreement with BioNuclear and Atlantic Medical International, respectively. In the aggregate, these agreements …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), the developer of hemodialysis products, reported a loss of $8.4 million or 26 cents a share for 2023, an improvement from a loss of $18.7 …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), developer and manufacturer of hemodialysis products, posted a loss of $1.9 million or 7 cents a share in the third quarter, vs. a loss of …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), which develops, manufactures, and distributes hemodialysis products to dialysis providers, announced a three-year product purchase agreement with Centers for Dialysis Care Inc., the largest non-profit, …
WIXOM–Rockwell Medical Inc. (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes hemodialysis products to dialysis providers worldwide, announced a three-year co-promotion services agreement with B. Braun Medical …
WIXOM, Mich.–Rockwell Medical Inc. (Nasdaq: RMTI), a manufacturer of products for patients suffering from blood disorders and diseases associated with the kidney, announced a three-year product purchase agreement with Concerto …